You are here

Lucitanib

Clovis spikes ovarian cancer combo after 'underwhelming' efficacy; Servier wins priority review for Tibsovo expansion

Endpoints

Wed, 05/5/21 - 10:42 am

Clovis Oncology

Bristol Myers Squibb

4 Key FDA Decisions Expected By Year End

24/7 Wall St

Sun, 11/29/15 - 12:43 pm

Tetraphase Pharmaceuticals

Clovis Oncology

Why Clovis Oncology Was Up 10% In After-Hours Trading Yesterday

Bidness Etc.

Thu, 09/11/14 - 08:20 am

Clovis Oncology

Clovis Oncology Announces Encouraging Data from Phase 1/2a Study Evaluating Lucitanib in Advanced Solid Tumors

Yahoo/BusinessWire

Sat, 05/31/14 - 10:09 am

Clovis Oncology

non-small cell lung cancer

3 Biotechs Generating a Lot Of Buzz

Wall St Cheat Sheet

Mon, 01/13/14 - 02:47 pm

Arrowhead Research

Clovis Oncology